Clinical Trial

HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation

Study acronym: HEALTH

Suspended Phase 1

View on ClinicalTrials.gov →

Why the trial stopped

Difficulty in finalising the intervention

Summary

This is a clinical trial to compare two formulations of the drug ivermectin: the standard 3mg tablet formulation versus a newly developed infant formula preparation. The goal of the trial is to determine if the new formulation functions in the same way, tastes the same and causes no new side effects. The trial will involve 52 participants who will be healthy adult volunteers. The participants will receive both formulations - the order they receive each formulation will be assigned randomly (similar to the toss of a coin).

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2025-04-01; most recent amendment 2026-03-19.

Status change: Not Yet Recruiting → Suspended 2025-12-08

Trial Details

NCT Number	NCT06918665
Lead Sponsor	Murdoch Childrens Research Institute Collaborators: Monash University
Conditions	Scabies
Enrollment	52 participants
Start Date	2026-07
Primary Completion	2027-07-01 (estimated)
Study Completion	2027-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-20